Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Pharmaceutical Companies in 2026
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2026, World Largest Pharmaceutical Companies by Market Cap in 2026.
  1. Alfresa Holdings Corporation

    World Rank (Aug-2026)
    5,613
    Market Cap (Aug-2026)
    2.489 Billion USD
    World Rank (Jan-05-2024)
    4,268
    Market Cap (Jan-05-2024)
    3.106 Billion USD
    World Rank (Jul-30-2023)
    4,263
    Market Cap (Jul-30-2023)
    3.089 Billion USD
    World Rank (Dec-25-2022)
    5,180
    Market Cap (Dec-25-2022)
    2.159 Billion USD
    World Rank (Jan-07-2022)
    5,016
    Market Cap (Jan-07-2022)
    2.86 Billion USD
    Annual Revenue in USD
    18,867 Million USD
    Annual Net Income in USD
    235 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile
    ALFRESA HOLDINGS CORPORATION deals with wholesaling, manufacturing, marketing and import/export of pharmaceuticals, diagnostic reagents, medical devices/equipment, etc., and operating dispensing pharmacies and conducting related businesses. The company annual revenue is 2,698.5 billion JPY, annual net income is 40.2 billion JPY, annual operating income is 47.6 billion JPY, total assets is 1,351.6 billion JPY, total liabilities is 876.7 billion JPY, total equity is 473.7 billion JPY as on 2020. The headquarters is in Japan.
  2. BioCryst Pharmaceuticals

    World Rank (Aug-2026)
    5,615
    Market Cap (Aug-2026)
    2.489 Billion USD
    World Rank (Jan-05-2024)
    7,310
    Market Cap (Jan-05-2024)
    1.323 Billion USD
    World Rank (Jul-30-2023)
    7,021
    Market Cap (Jul-30-2023)
    1.451 Billion USD
    World Rank (Dec-25-2022)
    5,228
    Market Cap (Dec-25-2022)
    2.135 Billion USD
    World Rank (Jan-07-2022)
    6,134
    Market Cap (Jan-07-2022)
    2.08 Billion USD
    Annual Revenue in USD
    875 Million USD
    Annual Operating Income in USD
    341 Million USD
    Annual Net Income in USD
    264 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    BioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.
  3. Nektar Therapeutics

    World Rank (Aug-2026)
    5,639
    Market Cap (Aug-2026)
    2.467 Billion USD
    World Rank (Jan-05-2024)
    21,027
    Market Cap (Jan-05-2024)
    0.108 Billion USD
    World Rank (Jul-30-2023)
    21,502
    Market Cap (Jul-30-2023)
    0.103 Billion USD
    World Rank (Dec-25-2022)
    13,797
    Market Cap (Dec-25-2022)
    0.404 Billion USD
    World Rank (Jan-07-2022)
    5,673
    Market Cap (Jan-07-2022)
    2.34 Billion USD
    Annual Revenue in USD
    55 Million USD
    Annual Operating Income in USD
    -140 Million USD
    Annual Net Income in USD
    -164 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Nektar Therapeutics is a research based development stage Biopharmaceutical company. It R&D pipeline of new investigational drugs includes treatments for cancer and auto immune disease and leverage Nektar's proprietary and proven chemistry platform in the discovery and design of new drug candidates. The headquarters is in USA.
  4. Yipinhong Pharmaceutical

    World Rank (Aug-2026)
    5,658
    Market Cap (Aug-2026)
    2.452 Billion USD
    World Rank (Jan-05-2024)
    5,991
    Market Cap (Jan-05-2024)
    1.838 Billion USD
    World Rank (Jul-30-2023)
    6,307
    Market Cap (Jul-30-2023)
    1.721 Billion USD
    World Rank (Dec-25-2022)
    7,017
    Market Cap (Dec-25-2022)
    1.351 Billion USD
    World Rank (Jan-07-2022)
    7,265
    Market Cap (Jan-07-2022)
    1.57 Billion USD
    Headquarters Country
  5. Shandong Buchang Pharmaceuticals

    World Rank (Aug-2026)
    5,672
    Market Cap (Aug-2026)
    2.436 Billion USD
    World Rank (Jan-05-2024)
    4,791
    Market Cap (Jan-05-2024)
    2.632 Billion USD
    World Rank (Jul-30-2023)
    4,174
    Market Cap (Jul-30-2023)
    3.183 Billion USD
    World Rank (Dec-25-2022)
    3,640
    Market Cap (Dec-25-2022)
    3.519 Billion USD
    World Rank (Jan-07-2022)
    4,123
    Market Cap (Jan-07-2022)
    3.73 Billion USD
    Annual Revenue in USD
    2,294 Million USD
    Annual Net Income in USD
    188 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Shandong Buchang Pharmaceuticals is specialized in the R&D (Research and development), production and sale of TCM (Traditional Chinese medicine) patent medicines, supplemented by many fields, i.e. hi tech industry and health industries company. It is having 7,923 employees as on 2019. The headquarters is in China.
  6. Bausch Health Companies

    World Rank (Aug-2026)
    5,673
    Market Cap (Aug-2026)
    2.435 Billion USD
    World Rank (Jan-05-2024)
    4,383
    Market Cap (Jan-05-2024)
    2.995 Billion USD
    World Rank (Jul-30-2023)
    3,918
    Market Cap (Jul-30-2023)
    3.484 Billion USD
    World Rank (Dec-25-2022)
    4,972
    Market Cap (Dec-25-2022)
    2.291 Billion USD
    World Rank (Jan-07-2022)
    1,934
    Market Cap (Jan-07-2022)
    9.71 Billion USD
    Annual Revenue in USD
    8,434 Million USD
    Annual Net Income in USD
    -948 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Bausch Health Companies is a pharmaceutical company. It engages in the development, manufacture, market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over the counter products. The headquarters is in Canada.

  7. China Resources Double-Crane Pharmaceutical

    World Rank (Aug-2026)
    5,713
    Market Cap (Aug-2026)
    2.407 Billion USD
    World Rank (Jan-05-2024)
    4,713
    Market Cap (Jan-05-2024)
    2.695 Billion USD
    World Rank (Jul-30-2023)
    4,983
    Market Cap (Jul-30-2023)
    2.472 Billion USD
    World Rank (Dec-25-2022)
    4,033
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    5,979
    Market Cap (Jan-07-2022)
    2.16 Billion USD
    Annual Revenue in USD
    1,326 Million USD
    Annual Net Income in USD
    136 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  8. Sankyo

    World Rank (Aug-2026)
    5,715
    Market Cap (Aug-2026)
    2.406 Billion USD
    World Rank (Jan-05-2024)
    4,682
    Market Cap (Jan-05-2024)
    2.715 Billion USD
    World Rank (Jul-30-2023)
    5,036
    Market Cap (Jul-30-2023)
    2.435 Billion USD
    World Rank (Dec-25-2022)
    4,940
    Market Cap (Dec-25-2022)
    2.313 Billion USD
    World Rank (Jan-07-2022)
    7,236
    Market Cap (Jan-07-2022)
    1.58 Billion USD
    Annual Revenue in USD
    7,625 Million USD
    Annual Net Income in USD
    489 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile
    Pharmaceutical company with headquarters is in Japan.
  9. Tonghua Dongbao Pharmaceutical

    World Rank (Aug-2026)
    5,776
    Market Cap (Aug-2026)
    2.360 Billion USD
    World Rank (Jan-05-2024)
    4,449
    Market Cap (Jan-05-2024)
    2.934 Billion USD
    World Rank (Jul-30-2023)
    4,488
    Market Cap (Jul-30-2023)
    2.878 Billion USD
    World Rank (Dec-25-2022)
    4,550
    Market Cap (Dec-25-2022)
    2.605 Billion USD
    World Rank (Jan-07-2022)
    4,314
    Market Cap (Jan-07-2022)
    3.54 Billion USD
    Annual Revenue in USD
    475 Million USD
    Annual Net Income in USD
    190 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    TONGHUA DONGBAO PHARMACEUTICAL is a pharmaceutical manufacturer company and it produces and sells pharmaceuticals, particularly Chinese patent medicines, chemical medicines and biological products. The headquarters is in China.
  10. China Grand Pharmaceutical and Healthcare Holdings

    World Rank (Aug-2026)
    5,794
    Market Cap (Aug-2026)
    2.347 Billion USD
    World Rank (Jan-05-2024)
    6,093
    Market Cap (Jan-05-2024)
    1.786 Billion USD
    World Rank (Jul-30-2023)
    5,709
    Market Cap (Jul-30-2023)
    2.021 Billion USD
    World Rank (Dec-25-2022)
    5,584
    Market Cap (Dec-25-2022)
    1.919 Billion USD
    World Rank (Jan-07-2022)
    5,047
    Market Cap (Jan-07-2022)
    2.84 Billion USD
    Annual Revenue in USD
    1,096 Million USD
    Annual Net Income in USD
    306 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    China Grand Pharmaceutical and Healthcare Holdings is a Pharmaceutical company. The company quarterly revenue is 93.5 million RMB as on 2020. The headquarters is in Hong Kong. 

Share

Ads